ClinConnect ClinConnect Logo
Search / Trial NCT06839742

Does Adding Posterior Block to SFIB Increase the Quality of Analgesia in Hip Fractures?

Launched by SAMSUN UNIVERSITY · Feb 17, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Acute Pain Management Hip Surgery Deep Posterior Gluteal Compartment Block Suprainguinal Fascia Iliaca Plane Block

ClinConnect Summary

This clinical trial is studying whether adding a specific type of pain relief technique, called a Deep Posterior Gluteal Compartment Block, to an existing pain management method called a Suprainguinal Fascia Iliaca Compartment Block can improve pain control for patients undergoing hip surgery. The researchers want to find out if this combination helps reduce pain better than just using the SFICB alone, especially in terms of how much pain medication patients need after surgery.

To participate in this study, patients must be between 18 and 90 years old and able to undergo surgery with spinal anesthesia for a procedure that lasts no longer than two hours. They should also be in good health, classified as ASA I, II, or III, meaning they have mild to moderate health issues. Participants will receive the assigned pain management techniques and will be monitored for their pain levels and medication needs during and after surgery. It's important to note that some people may not qualify due to certain medical conditions, allergies, or medications. If you or a family member are considering participating, you can learn more about what to expect and the eligibility requirements.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Volunteering to participate in the study
  • Patients between the ages of 18-90
  • ASA I, II, III
  • Patients whose surgery duration does not exceed 2 hours
  • Patients who will undergo surgery under spinal anesthesia
  • Exclusion Criteria:
  • Patients who do not want to participate in the study/do not give consent
  • Patients with a condition that prevents regional anesthesia
  • Patients with cognitive dysfunction who are unable to evaluate the NRS score and who cannot use PCA (Patient Controlled Analgesia Device)
  • History of hypersensitivity or allergy to local anesthetics
  • Patients with psychiatric disorders and those using psychiatric medications
  • Presence of hematological disease
  • Presence of oncological disease
  • Patients with serious major organ failure
  • Presence of multiple fractures
  • Patients with alcohol or drug addiction
  • Patients who have used analgesic drugs up to 12 hours before surgery
  • ASA IV-V patients
  • Morbidly obese patients

About Samsun University

Samsun University is a leading academic institution dedicated to advancing medical research and clinical innovation. Committed to improving healthcare outcomes, the university sponsors a range of clinical trials that focus on diverse therapeutic areas. With a robust infrastructure and a team of experienced researchers, Samsun University fosters collaboration between multidisciplinary experts to ensure the highest standards of scientific rigor and ethical compliance. By integrating cutting-edge technology and evidence-based practices, the university aims to contribute valuable insights to the medical community and enhance patient care through its clinical research initiatives.

Locations

Samsun, Ilkadım, Turkey

Samsun, , Turkey

Patients applied

0 patients applied

Trial Officials

HATİCE SELÇUK KUŞDERCİ

Study Director

SAMSUN UNİVERSITY

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported